# CAROSPIR
> **NDA209478** · New Drug Application · Sponsor: CMP DEV LLC · Approved 2017-08-04
## Drug
- **FDA Application Number:** NDA209478
- **Application type:** New Drug Application
- **Brand name:** CAROSPIR
- **Generic name:** SPIRONOLACTONE
- **Active ingredients:** SPIRONOLACTONE
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** CMP DEV LLC
- **Manufacturer:** Padagis US LLC
- **First approval:** 2017-08-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209478)
---
*MORVS · CC0 1.0*